Lanthanum Carbonate PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Dissociates in the gastrointestinal tract and binds dietary phosphate, forming insoluble lanthanum-phosphate complexes that are eliminated in faeces, reducing intestinal phosphate absorption.
Indications / reported uses
Control of serum phosphate in patients with chronic kidney disease on dialysis; chewable or oral-powder formulation must be taken with meals according to the product label
Identification source:PubChem record (CID 168924). The linked PubChem record is provided for identity reference. Confirm the exact salt, hydrate, isomer, mixture, or product form against authoritative source documentation when defining the assessment scope.
Dissociates in the gastrointestinal tract and binds dietary phosphate, forming insoluble lanthanum-phosphate complexes that are eliminated in faeces, reducing intestinal phosphate absorption.
General use cases
Control of serum phosphate in patients with chronic kidney disease on dialysis; chewable or oral-powder formulation must be taken with meals according to the product label
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
Assessment scope
Project-specific PDE/ADE and OEL/OEB support
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Lanthanum Carbonate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Lanthanum Carbonate Permitted Daily Exposure (PDE) report (the Lanthanum Carbonate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Lanthanum Carbonate Occupational Exposure Limit (OEL) report (the Lanthanum Carbonate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.